SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 83 filers reported holding SAVARA INC in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,676 | +492.2% | 859,418 | +371.1% | 0.00% | – |
Q4 2022 | $283 | -99.8% | 182,430 | +60.7% | 0.00% | – |
Q3 2022 | $176,000 | -26.1% | 113,501 | -27.4% | 0.00% | – |
Q2 2022 | $238,000 | +30.8% | 156,314 | +12.3% | 0.00% | – |
Q1 2022 | $182,000 | -62.2% | 139,221 | -64.2% | 0.00% | – |
Q4 2021 | $482,000 | +1.3% | 388,387 | +12.6% | 0.00% | – |
Q3 2021 | $476,000 | -85.7% | 344,960 | -82.4% | 0.00% | -100.0% |
Q2 2021 | $3,323,000 | +219.8% | 1,954,814 | +291.5% | 0.00% | +100.0% |
Q1 2021 | $1,039,000 | -25.7% | 499,366 | -11.1% | 0.00% | -50.0% |
Q2 2020 | $1,399,000 | -0.3% | 561,798 | -15.1% | 0.00% | -33.3% |
Q1 2020 | $1,403,000 | +1632.1% | 661,925 | +3578.6% | 0.00% | – |
Q4 2019 | $81,000 | -66.0% | 17,994 | -80.0% | 0.00% | – |
Q3 2019 | $238,000 | -88.3% | 89,932 | -89.5% | 0.00% | -100.0% |
Q2 2019 | $2,036,000 | +85.9% | 859,101 | +478.5% | 0.00% | +50.0% |
Q1 2019 | $1,095,000 | +53.4% | 148,517 | +57.4% | 0.00% | +100.0% |
Q4 2018 | $714,000 | -58.1% | 94,365 | -37.3% | 0.00% | -50.0% |
Q2 2018 | $1,703,000 | -64.6% | 150,416 | -71.2% | 0.00% | -66.7% |
Q1 2018 | $4,811,000 | +682.3% | 522,897 | +1161.8% | 0.01% | +500.0% |
Q4 2017 | $615,000 | -78.1% | 41,441 | -86.2% | 0.00% | -75.0% |
Q3 2017 | $2,811,000 | – | 300,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |